Certara Products - Simcyp Archives | 第 2 页，共 27 页 | Certara

Poster

将内源性配体竞争纳入治疗性单克隆抗体的机制全身 PBPK 模型

Discover how endogenous ligand competition was incorporated into a whole-body PBPK model to improve prediction…

Certara2026 年 6 月 23 日

Poster

Machine Learning based drug renal clearance predictor development and application

A machine learning QSAR model predicts human renal clearance from simple, easy-to-obtain inputs and sharpens…

Certara2026 年 6 月 22 日

Brochure

2026 Simcyp Workshops

Advance your PBPK and model-informed drug development expertise with Simcyp workshops. Learn from experts through…

Certara2026 年 6 月 11 日

Press Coverage

支持模拟孕妇用药剂量的理由

孕妇通常被排除在药物临床试验之外，这使得临床医生缺乏用药剂量的指导。Discover how…

Certara2026 年 6 月 9 日

Publication

Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib

This publication reports a pooled retrospective analysis evaluating growth patterns in children with B-Raf proto-oncogene…

Dorottya Gui-Bodnar2026 年 5 月 28 日

On-Demand Webinar

The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators

Learn how PBPK and QSP modeling support regulatory confidence, accelerate drug development, and align with…

Certara2026 年 5 月 26 日

Live Events

Simcyp 专题研讨会：DDI（复杂药物相互作用的预测与评估）日本

Certara2026 年 5 月 20 日

Live Events

Simcyp 线下研讨会：PBPK 建模在生物药剂学中的应用 — 日本

Certara2026 年 5 月 19 日

Guide

如何在药物研发中运用 PBPK 建模与模拟

Learn how PBPK modeling and simulation in drug research and development reduces clinical burden, supports…

Certara2026 年 5 月 12 日

Webinar

Minimize risk when preparing for hepatic impairment studies

Certara2026 年 5 月 12 日

© 2026 Certara. 保留所有权力。 | 法律 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software